| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |